1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Heart Failure, Reduced Ejection Fraction: new trials by email Literature Review of Heart Failure, Reduced Ejection Fraction trials Research Report on Heart Failure, Reduced Ejection Fraction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study on the Effects of Sacubitril/Valsartan on Physical Activity and Sleep in Heart Failure With Reduced Ejection Fraction Patients. sacubitril/valsartan (LCZ696), enalapril, matching placebo sacubitril/valsartan (LCZ696) - Heart Failure, Reduced Ejection Fraction | Phase 4 | Completed | Novartis Pharmaceuticals | 140 | 2016-12-16 | 2021-10-07 |
Dilatation, Pathologic (1) · Heart Failure (1) · Heart Failure, Systolic (1) · Hypertrophy, Left Ventricular (1) · Motor Activity (1)
Behavior (1) · Cardiomegaly (1) · Cardiovascular Diseases (1) · Heart Diseases (1) · Hypertrophy (1) · Pathological Conditions, Anatomical (1) · Pathological Conditions, Signs and Symptoms (1)
Enalapril (1) · Valsartan (1) · sacubitril (1) · sacubitril and valsartan sodium hydrate drug combination (1)
United States (1)